On the mechanisms involved in biological heme crystallization |
| |
Authors: | Renata?Stiebler,Juliana?B.?R.?Correa?Soares,Bruno?L.?Timm,José?Roberto?Silva,Flavia?B.?Mury,Marilvia?Dansa-Petretski mailto:marilvia@uenf.br" title=" marilvia@uenf.br" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author,Marcus?F.?Oliveira mailto:maroli@bioqmed.ufrj.br" title=" maroli@bioqmed.ufrj.br" itemprop=" email" data-track=" click" data-track-action=" Email author" data-track-label=" " >Email author |
| |
Affiliation: | (1) Present address: School of Biochemistry, Genetics, Microbiology and Plant Pathology, University of KwaZulu-Natal, P.O. Box XO1, Scottsville, 3209 Pietermaritzburg, South Africa |
| |
Abstract: | Blood-feeding organisms digest hemoglobin, releasing large quantities of heme inside their digestive tracts. Free heme is very toxic, and these organisms have evolved several mechanisms to protect against its deleterious effects. One of these adaptations is the crystallization of heme into the dark-brown pigment hemozoin (Hz). Here we review the process of Hz formation, focusing on organisms other than Plasmodium that have contributed to a better understanding of heme crystallization. Hemozoin has been found in several distinct classes of organisms including protozoa, helminths and insects and Hz formation is the predominant form of heme detoxification. The available evidence indicates that amphiphilic structures such as phospholipid membranes and lipid droplets accompanied by specific proteins play a major role in heme crystallization. Because this process is specific to a number of blood-feeding organisms and absent in their hosts, Hz formation is an attractive target for the development of novel drugs to control illnesses associated with these hematophagous organisms. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|